vtx3232
vtx3232: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ventyx Biosciences, Inc. (VTYX) | Phase 2 |
FDA Decisions
Approval(VTYX)
Frequently asked questions
Who is developing vtx3232?
vtx3232 is being developed by Ventyx Biosciences, Inc..
What is vtx3232's latest FDA decision?
The most recent tracked FDA decision for vtx3232 is Approval, dated February 23, 2026.
Get deeper analysis on vtx3232
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis